グルコース依存性インスリン分泌性受容体の世界市場（～2026年）

• 英文タイトル：Global Glucose Dependent Insulinotropic Receptor Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY06855 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はグルコース依存性インスリン分泌性受容体のグローバル市場について調査・分析したレポートです。種類別（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他）市場規模、用途別（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別グルコース依存性インスリン分泌性受容体の競争状況、市場シェア ・世界のグルコース依存性インスリン分泌性受容体市場：種類別市場規模 2015年-2020年（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他） ・世界のグルコース依存性インスリン分泌性受容体市場：種類別市場規模予測 2021年-2026年（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他） ・世界のグルコース依存性インスリン分泌性受容体市場：用途別市場規模 2015年-2020年（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他） ・世界のグルコース依存性インスリン分泌性受容体市場：用途別市場規模予測 2021年-2026年（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他） ・北米のグルコース依存性インスリン分泌性受容体市場分析：米国、カナダ ・ヨーロッパのグルコース依存性インスリン分泌性受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのグルコース依存性インスリン分泌性受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のグルコース依存性インスリン分泌性受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのグルコース依存性インスリン分泌性受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen Inc、Arena Pharmaceuticals Inc、CymaBay Therapeutics Inc、Dong-A Socio Holdings Co Ltd、F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc、Hyundai Pharmaceutical Co Ltd、Kowa Co Ltd、Merck & Co Inc、Novartis AG、Taisho Pharmaceutical Holdings Co Ltd、Takeda Pharmaceutical Co Ltd、Yuhan Corp ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Glucose Dependent Insulinotropic Receptor Market
The global Glucose Dependent Insulinotropic Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Glucose Dependent Insulinotropic Receptor Scope and Market Size
Glucose Dependent Insulinotropic Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucose Dependent Insulinotropic Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Glucose Dependent Insulinotropic Receptor market is segmented into
DA-1241
GSK-2041706
HD-0471042
HD-0471953
HOB-047
MBX-2982
Others

Segment by Application, the Glucose Dependent Insulinotropic Receptor market is segmented into
Type 2 Diabetes
Obesity
Chronic Obstructive Pulmonary Disease (COPD)
Dyslipidemia
Others

Regional and Country-level Analysis
The Glucose Dependent Insulinotropic Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glucose Dependent Insulinotropic Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glucose Dependent Insulinotropic Receptor Market Share Analysis
Glucose Dependent Insulinotropic Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glucose Dependent Insulinotropic Receptor business, the date to enter into the Glucose Dependent Insulinotropic Receptor market, Glucose Dependent Insulinotropic Receptor product introduction, recent developments, etc.

The major vendors covered:
Amgen Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Dong-A Socio Holdings Co Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Hyundai Pharmaceutical Co Ltd
Kowa Co Ltd
Merck & Co Inc
Novartis AG
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp

レポート目次

---

1 Study Coverage
1.1 Glucose Dependent Insulinotropic Receptor Product Introduction
1.2 Market Segments
1.3 Key Glucose Dependent Insulinotropic Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type
1.4.2 DA-1241
1.4.3 GSK-2041706
1.4.4 HD-0471042
1.4.5 HD-0471953
1.4.6 HOB-047
1.4.7 MBX-2982
1.4.8 Others
1.5 Market by Application
1.5.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Application
1.5.2 Type 2 Diabetes
1.5.3 Obesity
1.5.4 Chronic Obstructive Pulmonary Disease (COPD)
1.5.5 Dyslipidemia
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Glucose Dependent Insulinotropic Receptor Market Size, Estimates and Forecasts
2.1.1 Global Glucose Dependent Insulinotropic Receptor Revenue 2015-2026
2.1.2 Global Glucose Dependent Insulinotropic Receptor Sales 2015-2026
2.2 Global Glucose Dependent Insulinotropic Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glucose Dependent Insulinotropic Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glucose Dependent Insulinotropic Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Glucose Dependent Insulinotropic Receptor Competitor Landscape by Players
3.1 Glucose Dependent Insulinotropic Receptor Sales by Manufacturers
3.1.1 Glucose Dependent Insulinotropic Receptor Sales by Manufacturers (2015-2020)
3.1.2 Glucose Dependent Insulinotropic Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers
3.2.1 Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Glucose Dependent Insulinotropic Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glucose Dependent Insulinotropic Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glucose Dependent Insulinotropic Receptor Revenue in 2019
3.2.5 Global Glucose Dependent Insulinotropic Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glucose Dependent Insulinotropic Receptor Price by Manufacturers
3.4 Glucose Dependent Insulinotropic Receptor Manufacturing Base Distribution, Product Types
3.4.1 Glucose Dependent Insulinotropic Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucose Dependent Insulinotropic Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Glucose Dependent Insulinotropic Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2015-2020)
4.1.1 Global Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020)
4.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue by Type (2015-2020)
4.1.3 Glucose Dependent Insulinotropic Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glucose Dependent Insulinotropic Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Glucose Dependent Insulinotropic Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glucose Dependent Insulinotropic Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2015-2020)
5.1.1 Global Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020)
5.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue by Application (2015-2020)
5.1.3 Glucose Dependent Insulinotropic Receptor Price by Application (2015-2020)
5.2 Glucose Dependent Insulinotropic Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucose Dependent Insulinotropic Receptor Price Forecast by Application (2021-2026)

6 North America
6.1 North America Glucose Dependent Insulinotropic Receptor by Country
6.1.1 North America Glucose Dependent Insulinotropic Receptor Sales by Country
6.1.2 North America Glucose Dependent Insulinotropic Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Type
6.3 North America Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Application

7 Europe
7.1 Europe Glucose Dependent Insulinotropic Receptor by Country
7.1.1 Europe Glucose Dependent Insulinotropic Receptor Sales by Country
7.1.2 Europe Glucose Dependent Insulinotropic Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Type
7.3 Europe Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Glucose Dependent Insulinotropic Receptor by Region
8.1.1 Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Region
8.1.2 Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Type
8.3 Asia Pacific Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Application

9 Latin America
9.1 Latin America Glucose Dependent Insulinotropic Receptor by Country
9.1.1 Latin America Glucose Dependent Insulinotropic Receptor Sales by Country
9.1.2 Latin America Glucose Dependent Insulinotropic Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Type
9.3 Central & South America Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Glucose Dependent Insulinotropic Receptor by Country
10.1.1 Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Country
10.1.2 Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Facts & Figures by Application

11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.1.5 Amgen Inc Related Developments
11.2 Arena Pharmaceuticals Inc
11.2.1 Arena Pharmaceuticals Inc Corporation Information
11.2.2 Arena Pharmaceuticals Inc Description and Business Overview
11.2.3 Arena Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.2.5 Arena Pharmaceuticals Inc Related Developments
11.3 CymaBay Therapeutics Inc
11.3.1 CymaBay Therapeutics Inc Corporation Information
11.3.2 CymaBay Therapeutics Inc Description and Business Overview
11.3.3 CymaBay Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.3.5 CymaBay Therapeutics Inc Related Developments
11.4 Dong-A Socio Holdings Co Ltd
11.4.1 Dong-A Socio Holdings Co Ltd Corporation Information
11.4.2 Dong-A Socio Holdings Co Ltd Description and Business Overview
11.4.3 Dong-A Socio Holdings Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.4.5 Dong-A Socio Holdings Co Ltd Related Developments
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.5.5 F. Hoffmann-La Roche Ltd Related Developments
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Corporation Information
11.6.2 GlaxoSmithKline Plc Description and Business Overview
11.6.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Products Offered
11.6.5 GlaxoSmithKline Plc Related Developments
11.7 Hyundai Pharmaceutical Co Ltd
11.7.1 Hyundai Pharmaceutical Co Ltd Corporation Information
11.7.2 Hyundai Pharmaceutical Co Ltd Description and Business Overview
11.7.3 Hyundai Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.7.5 Hyundai Pharmaceutical Co Ltd Related Developments
11.8 Kowa Co Ltd
11.8.1 Kowa Co Ltd Corporation Information
11.8.2 Kowa Co Ltd Description and Business Overview
11.8.3 Kowa Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.8.5 Kowa Co Ltd Related Developments
11.9 Merck & Co Inc
11.9.1 Merck & Co Inc Corporation Information
11.9.2 Merck & Co Inc Description and Business Overview
11.9.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.9.5 Merck & Co Inc Related Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Description and Business Overview
11.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG Glucose Dependent Insulinotropic Receptor Products Offered
11.10.5 Novartis AG Related Developments
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.1.5 Amgen Inc Related Developments
11.12 Takeda Pharmaceutical Co Ltd
11.12.1 Takeda Pharmaceutical Co Ltd Corporation Information
11.12.2 Takeda Pharmaceutical Co Ltd Description and Business Overview
11.12.3 Takeda Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Takeda Pharmaceutical Co Ltd Products Offered
11.12.5 Takeda Pharmaceutical Co Ltd Related Developments
11.13 Yuhan Corp
11.13.1 Yuhan Corp Corporation Information
11.13.2 Yuhan Corp Description and Business Overview
11.13.3 Yuhan Corp Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Yuhan Corp Products Offered
11.13.5 Yuhan Corp Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glucose Dependent Insulinotropic Receptor Market Estimates and Projections by Region
12.1.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Glucose Dependent Insulinotropic Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Glucose Dependent Insulinotropic Receptor Sales Forecast (2021-2026)
12.2.2 North America: Glucose Dependent Insulinotropic Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Glucose Dependent Insulinotropic Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Glucose Dependent Insulinotropic Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Glucose Dependent Insulinotropic Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glucose Dependent Insulinotropic Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glucose Dependent Insulinotropic Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glucose Dependent Insulinotropic Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glucose Dependent Insulinotropic Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Glucose Dependent Insulinotropic Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Glucose Dependent Insulinotropic Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Glucose Dependent Insulinotropic Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glucose Dependent Insulinotropic Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glucose Dependent Insulinotropic Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glucose Dependent Insulinotropic Receptor Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glucose Dependent Insulinotropic Receptor Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucose Dependent Insulinotropic Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Glucose Dependent Insulinotropic Receptor Market Segments
Table 2. Ranking of Global Top Glucose Dependent Insulinotropic Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of DA-1241
Table 5. Major Manufacturers of GSK-2041706
Table 6. Major Manufacturers of HD-0471042
Table 7. Major Manufacturers of HD-0471953
Table 8. Major Manufacturers of HOB-047
Table 9. Major Manufacturers of MBX-2982
Table 10. Major Manufacturers of Others
Table 11. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Glucose Dependent Insulinotropic Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Glucose Dependent Insulinotropic Receptor Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions (2015-2020)
Table 15. Global Glucose Dependent Insulinotropic Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Glucose Dependent Insulinotropic Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Glucose Dependent Insulinotropic Receptor Sales Share by Manufacturers (2015-2020)
Table 18. Global Glucose Dependent Insulinotropic Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Glucose Dependent Insulinotropic Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucose Dependent Insulinotropic Receptor as of 2019)
Table 20. Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Glucose Dependent Insulinotropic Receptor Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Glucose Dependent Insulinotropic Receptor Price (2015-2020) (USD/Pcs)
Table 23. Glucose Dependent Insulinotropic Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Glucose Dependent Insulinotropic Receptor Product Type
Table 25. Date of International Manufacturers Enter into Glucose Dependent Insulinotropic Receptor Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 28. Global Glucose Dependent Insulinotropic Receptor Sales Share by Type (2015-2020)
Table 29. Global Glucose Dependent Insulinotropic Receptor Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Type (2015-2020)
Table 31. Glucose Dependent Insulinotropic Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 33. Global Glucose Dependent Insulinotropic Receptor Sales Share by Application (2015-2020)
Table 34. North America Glucose Dependent Insulinotropic Receptor Sales by Country (2015-2020) (K Pcs)
Table 35. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Country (2015-2020)
Table 36. North America Glucose Dependent Insulinotropic Receptor Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2015-2020)
Table 38. North America Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 39. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2015-2020)
Table 40. North America Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 41. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
Table 42. Europe Glucose Dependent Insulinotropic Receptor Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Country (2015-2020)
Table 44. Europe Glucose Dependent Insulinotropic Receptor Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2015-2020)
Table 46. Europe Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2015-2020)
Table 48. Europe Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
Table 58. Latin America Glucose Dependent Insulinotropic Receptor Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Glucose Dependent Insulinotropic Receptor Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Glucose Dependent Insulinotropic Receptor Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2015-2020)
Table 62. Latin America Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2015-2020)
Table 64. Latin America Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
Table 74. Amgen Inc Corporation Information
Table 75. Amgen Inc Description and Major Businesses
Table 76. Amgen Inc Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Amgen Inc Product
Table 78. Amgen Inc Recent Development
Table 79. Arena Pharmaceuticals Inc Corporation Information
Table 80. Arena Pharmaceuticals Inc Description and Major Businesses
Table 81. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Arena Pharmaceuticals Inc Product
Table 83. Arena Pharmaceuticals Inc Recent Development
Table 84. CymaBay Therapeutics Inc Corporation Information
Table 85. CymaBay Therapeutics Inc Description and Major Businesses
Table 86. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. CymaBay Therapeutics Inc Product
Table 88. CymaBay Therapeutics Inc Recent Development
Table 89. Dong-A Socio Holdings Co Ltd Corporation Information
Table 90. Dong-A Socio Holdings Co Ltd Description and Major Businesses
Table 91. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Dong-A Socio Holdings Co Ltd Product
Table 93. Dong-A Socio Holdings Co Ltd Recent Development
Table 94. F. Hoffmann-La Roche Ltd Corporation Information
Table 95. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 96. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. F. Hoffmann-La Roche Ltd Product
Table 98. F. Hoffmann-La Roche Ltd Recent Development
Table 99. GlaxoSmithKline Plc Corporation Information
Table 100. GlaxoSmithKline Plc Description and Major Businesses
Table 101. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. GlaxoSmithKline Plc Product
Table 103. GlaxoSmithKline Plc Recent Development
Table 104. Hyundai Pharmaceutical Co Ltd Corporation Information
Table 105. Hyundai Pharmaceutical Co Ltd Description and Major Businesses
Table 106. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Hyundai Pharmaceutical Co Ltd Product
Table 108. Hyundai Pharmaceutical Co Ltd Recent Development
Table 109. Kowa Co Ltd Corporation Information
Table 110. Kowa Co Ltd Description and Major Businesses
Table 111. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Kowa Co Ltd Product
Table 113. Kowa Co Ltd Recent Development
Table 114. Merck & Co Inc Corporation Information
Table 115. Merck & Co Inc Description and Major Businesses
Table 116. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Merck & Co Inc Product
Table 118. Merck & Co Inc Recent Development
Table 119. Novartis AG Corporation Information
Table 120. Novartis AG Description and Major Businesses
Table 121. Novartis AG Glucose Dependent Insulinotropic Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Novartis AG Product
Table 123. Novartis AG Recent Development
Table 124. Taisho Pharmaceutical Holdings Co Ltd Corporation Information
Table 125. Taisho Pharmaceutical Holdings Co Ltd Description and Major Businesses
Table 126. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Taisho Pharmaceutical Holdings Co Ltd Product
Table 128. Taisho Pharmaceutical Holdings Co Ltd Recent Development
Table 129. Takeda Pharmaceutical Co Ltd Corporation Information
Table 130. Takeda Pharmaceutical Co Ltd Description and Major Businesses
Table 131. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Takeda Pharmaceutical Co Ltd Product
Table 133. Takeda Pharmaceutical Co Ltd Recent Development
Table 134. Yuhan Corp Corporation Information
Table 135. Yuhan Corp Description and Major Businesses
Table 136. Yuhan Corp Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Yuhan Corp Product
Table 138. Yuhan Corp Recent Development
Table 139. Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Glucose Dependent Insulinotropic Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Glucose Dependent Insulinotropic Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Glucose Dependent Insulinotropic Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Glucose Dependent Insulinotropic Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Glucose Dependent Insulinotropic Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Glucose Dependent Insulinotropic Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Glucose Dependent Insulinotropic Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Glucose Dependent Insulinotropic Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Glucose Dependent Insulinotropic Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Glucose Dependent Insulinotropic Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Glucose Dependent Insulinotropic Receptor Players
Table 157. Glucose Dependent Insulinotropic Receptor Customers List
Table 158. Glucose Dependent Insulinotropic Receptor Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucose Dependent Insulinotropic Receptor Product Picture
Figure 2. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. DA-1241 Product Picture
Figure 4. GSK-2041706 Product Picture
Figure 5. HD-0471042 Product Picture
Figure 6. HD-0471953 Product Picture
Figure 7. HOB-047 Product Picture
Figure 8. MBX-2982 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Application in 2020 & 2026
Figure 11. Type 2 Diabetes
Figure 12. Obesity
Figure 13. Chronic Obstructive Pulmonary Disease (COPD)
Figure 14. Dyslipidemia
Figure 15. Others
Figure 16. Glucose Dependent Insulinotropic Receptor Report Years Considered
Figure 17. Global Glucose Dependent Insulinotropic Receptor Market Size 2015-2026 (US$ Million)
Figure 18. Global Glucose Dependent Insulinotropic Receptor Sales 2015-2026 (K Pcs)
Figure 19. Global Glucose Dependent Insulinotropic Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Region (2015-2020)
Figure 21. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Region in 2019
Figure 22. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region (2015-2020)
Figure 23. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region in 2019
Figure 24. Global Glucose Dependent Insulinotropic Receptor Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Glucose Dependent Insulinotropic Receptor Revenue in 2019
Figure 26. Glucose Dependent Insulinotropic Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Type (2015-2020)
Figure 28. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Type in 2019
Figure 29. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2015-2020)
Figure 30. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type in 2019
Figure 31. Global Glucose Dependent Insulinotropic Receptor Market Share by Price Range (2015-2020)
Figure 32. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
Figure 33. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Application in 2019
Figure 34. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2015-2020)
Figure 35. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application in 2019
Figure 36. North America Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 37. North America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Country in 2019
Figure 39. North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country in 2019
Figure 40. U.S. Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. U.S. Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Canada Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Glucose Dependent Insulinotropic Receptor Market Share by Type in 2019
Figure 45. North America Glucose Dependent Insulinotropic Receptor Market Share by Application in 2019
Figure 46. Europe Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 47. Europe Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Country in 2019
Figure 49. Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country in 2019
Figure 50. Germany Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Germany Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. France Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. U.K. Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Italy Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Glucose Dependent Insulinotropic Receptor Market Share by Type in 2019
Figure 61. Europe Glucose Dependent Insulinotropic Receptor Market Share by Application in 2019
Figure 62. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Region in 2019
Figure 65. Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Market Share by Region in 2019
Figure 66. China Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Glucose Dependent Insulinotropic Receptor Market Share by Type in 2019
Figure 89. Asia Pacific Glucose Dependent Insulinotropic Receptor Market Share by Application in 2019
Figure 90. Latin America Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Glucose Dependent Insulinotropic Receptor Sales Market Share by Country in 2019
Figure 93. Latin America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country in 2019
Figure 94. Mexico Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Type in 2019
Figure 101. Latin America Glucose Dependent Insulinotropic Receptor Market Share by Application in 2019
Figure 102. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 103. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Country in 2019
Figure 106. Turkey Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Turkey Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. Saudi Arabia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. U.A.E Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Share by Type in 2019
Figure 113. Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Share by Application in 2019
Figure 114. North America Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed

---